The crystal structure of t-butyl 7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate, C28H34FNO4-Reference-Cited by-同舟云学术

The crystal structure of t-butyl 7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate, C₂₈H₃₄FNO₄

Published:2024-03-14 Issue:3 Volume:239 Page:367-369
ISSN:1433-7266
Container-title:Zeitschrift für Kristallographie - New Crystal Structures
language:en
Short-container-title:

Author:

Alex Vergiro Tchuente Fofeu¹,Xie Tai-Yang²,Zou Jing¹,Xu Xin-Xin¹,Xu Rou-Han¹,Jiang Cheng-Jun¹^ORCID

Affiliation:

1. School of Biological and Chemical Engineering , Zhejiang University of Science and Technology , Liuhe Road 318# , Hangzhou , China

2. Zhejiang Lepu Pharmaceutical Co., Ltd. , Binhai Road 29# , Taizhou , China

Abstract

Abstract C28H34FNO4, monoclinic, C2/c (no. 15), a = 21.7795(12) Å, b = 5.9103(4) Å, c = 39.830(2) Å, β = 100.866(3)°, V = 5035.1(5) Å3, Z = 8, R gt(F) = 0.0487, wR ref(F 2) = 0.1376, T = 170 K.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/ncrs-2024-0002/pdf

Reference7 articles.

1. Bruker. Apex3 v. 2016.9-0 and Saint v. 8.37A; Bruker Axs Inc.: Madison, Wisconsin, USA, 2016.

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.

3. Sheldrick, G. M. SHELXTL – Integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8.

4. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.

5. Plosker, G. L., Wagstaff, A. J. Fluvastatin. Drugs 1996, 51, 433–459; https://doi.org/10.2165/00003495-199651030-00011.